secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0000719135-23-000066
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical appoints Matthew Hill as CFO effective Dec 4, 2023
---------------------------------------------------------------

- Matthew Hill appointed CFO, effective Dec 4, 2023, succeeding Tara Semb who departed Nov 9.
- Hill brings 30+ years experience, previously CFO of PDS Biotech, Strata Skin Sciences, and other healthcare firms.
- Employment terms: $425K base salary, $50K sign-on bonus, target bonus ≥50% of base, stock option for 150K shares.
- Hill will also serve as Principal Financial Officer and Principal Accounting Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000071913523000066/0000719135-23-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000071913523000066/apyx-20231121.htm
  HTML page:      https://secwatch.observer/filing/0000719135-23-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer